CGEM
Cullinan Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$15.45
−0.71%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.84
- Revenue estimate
- $2.0M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.81
- EPS estimate
- -$0.80
- Revenue actual
- —
- Revenue estimate
- $3.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +8.2%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $39
- PT range
- $35 – $42
- Analysts
- 4
4 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.80 | -$0.81 | Miss -1.34% | — |
| May 7, 2026 | -$0.84 | -$0.75 | Beat 10.27% | — |
| Mar 10, 2026 | -$0.81 | -$0.77 | Beat 4.87% | — |
| Nov 6, 2025 | -$0.95 | -$0.77 | Beat 18.95% | — |
| Aug 7, 2025 | -$0.83 | -$1.07 | Miss -28.92% | — |
| May 8, 2025 | -$0.78 | -$0.74 | Beat 5.13% | — |
| Feb 27, 2025 | -$0.75 | -$0.73 | Beat 2.67% | — |
| Nov 7, 2024 | -$0.78 | -$0.69 | Beat 11.54% | — |
| Aug 8, 2024 | -$0.73 | -$0.75 | Miss -2.74% | — |
| May 15, 2024 | -$0.90 | -$0.86 | Beat 4.44% | — |
| Mar 14, 2024 | -$0.96 | -$0.54 | Beat 43.75% | — |
| Aug 10, 2023 | -$0.99 | -$0.82 | Beat 17.17% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026